keyword
https://read.qxmd.com/read/38653928/management-of-early-stage-her2-positive-breast-cancer-and-attitudes-towards-her2dx-test-in-spain-insights-from-a-nationwide-survey
#1
JOURNAL ARTICLE
Olga Martínez-Sáez, Javier Cortés, Eva Ciruelos, Mercedes Marín-Aguilera, Gloria González, Laia Paré, Adriana Herrera, Patricia Villagrasa-González, Aleix Prat, Miguel Martín
PURPOSE: This study aimed to investigate the current therapeutic management of patients with early-stage HER2-positive (HER2+) breast cancer in Spain, while also exploring the perceptions surrounding HER2DX in terms of its credibility, clinical relevance, and impact on therapeutic decision-making. Understanding these aspects is crucial for optimizing treatment strategies and enhancing patient outcomes in the context of HER2+ breast cancer. METHODS: An online questionnaire was conducted by an independent third-party between April and May 2022 across 70 medical oncologists highly specialized in breast cancer management in Spain...
April 23, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38652937/racial-disparities-in-breast-cancer-risk-factors-and-risk-management
#2
REVIEW
Holly J Pederson, Zahraa Al-Hilli, Allison W Kurian
Racial disparities in breast cancer outcomes are well described across the spectrum of screening, diagnosis, treatment, and survivorship. Breast cancer mortality is markedly elevated for Non-Hispanic Black women compared with other racial and ethnic groups, with multifactorial causes. Here, we aim to reduce this burden by identifying disparities in breast cancer risk factors, risk assessment, and risk management before breast cancer is diagnosed. We describe a reproductive profile and modifiable risk factors specific to the development of triple-negative breast cancer...
February 29, 2024: Maturitas
https://read.qxmd.com/read/38652271/exploring-the-effect-of-brca1-2-status-on-chemotherapy-induced-hematologic-toxicity-in-patients-with-ovarian-cancer
#3
JOURNAL ARTICLE
In Hee Lee, Soo Jung Lee, Juhyung Kim, Yoon Hee Lee, Gun Oh Chong, Jong Mi Kim, Juhun Lee, Nan Young Lee, Seo Young Park, Dea Gy Hong, Yee Soo Chae
OBJECTIVE: BRCA1/2 are integral to the DNA repair mechanism and their germline pathogenic variants (gBRCA) result in a high risk for developing breast and ovarian cancer. Patients with gBRCA mutations showed increased sensitivity to DNA cross-linking agent but might have increased treatment-related toxicities. Thus, we hypothesized that gBRCA mutation ovarian cancer patients who underwent platinum-based chemotherapy might be at higher risk of developing chemotherapy-induced hematologic toxicity...
April 23, 2024: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/38651681/fulfilling-the-role-of-a-parent-while-undergoing-treatment-for-cancer-a-review-of-the-literature-and-the-potential-impact-of-childcare-support-on-cancer-outcomes
#4
JOURNAL ARTICLE
Kang Woo Kim, Mary Lopresti, Stephanie L Graff, Sabrina Witherby, Don S Dizon, Mary Anne Fenton
Breast cancer is the most prevalent malignancy among adolescents and young adults (AYAs). Despite the efficacy of chemotherapy, AYA patients contend with psychosocial challenges, including psychological distress and financial toxicity, exacerbated further by those with dependent children. Parenting responsibilities intersect with cancer care, impacting both family dynamics and treatment adherence. Despite recognized needs, however, the impact of parenting concerns or even parenting status and the presence of dependents has not been systematically addressed and there is a paucity of interventional research regarding patients with cancer as concomitant caregivers...
April 23, 2024: American Journal of Clinical Oncology
https://read.qxmd.com/read/38651430/surgical-outcomes-and-complications-of-custom-made-prostheses-in-upper-limb-oncological-reconstruction-a-systematic-review
#5
REVIEW
Camillo Fulchignoni, Silvia Pietramala, Ivo Lopez, Giovan Giuseppe Mazzella, Chiara Comisi, Carlo Perisano, Lorenzo Rocchi, Tommaso Greco
Bone tumors of the upper limb are a common cause of bone pain and pathological fractures in both old and young populations. Surgical reconstruction and limb salvage have become valid options for these patients despite this kind of surgery being challenging due to the need for wide bone resection and the involvement of surrounding soft tissues. Computer-assisted technology helps the surgeon in pre-operative planning and in designing customized implants. The aim of this study was to investigate the surgical outcomes and complications of custom-made prostheses in oncologic reconstruction of the upper limb and if they are reliable options for patients suffering from aggressive tumors...
April 11, 2024: Journal of Functional Morphology and Kinesiology
https://read.qxmd.com/read/38649889/screening-mammography-performance-according-to-breast-density-a-comparison-between-radiologists-versus-standalone-intelligence-detection
#6
JOURNAL ARTICLE
Mi-Ri Kwon, Yoosoo Chang, Soo-Youn Ham, Yoosun Cho, Eun Young Kim, Jeonggyu Kang, Eun Kyung Park, Ki Hwan Kim, Minjeong Kim, Tae Soo Kim, Hyeonsoo Lee, Ria Kwon, Ga-Young Lim, Hye Rin Choi, JunHyeok Choi, Shin Ho Kook, Seungho Ryu
BACKGROUND: Artificial intelligence (AI) algorithms for the independent assessment of screening mammograms have not been well established in a large screening cohort of Asian women. We compared the performance of screening digital mammography considering breast density, between radiologists and AI standalone detection among Korean women. METHODS: We retrospectively included 89,855 Korean women who underwent their initial screening digital mammography from 2009 to 2020...
April 22, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38649821/long-non-coding-rna-sox2ot-in-tamoxifen-resistant-breast-cancer
#7
JOURNAL ARTICLE
Jeeyeon Lee, Eun-Ae Kim, Jieun Kang, Yee Soo Chae, Ho Yong Park, Byeongju Kang, Soo Jung Lee, In Hee Lee, Ji-Young Park, Nora Jee-Young Park, Jin Hyang Jung
Hormone receptor (HR)-positive breast cancer can become aggressive after developing hormone-treatment resistance. This study elucidated the role of long non-coding RNA (lncRNA) SOX2OT in tamoxifen-resistant (TAMR) breast cancer and its potential interplay with the tumor microenvironment (TME). TAMR breast cancer cell lines TAMR-V and TAMR-H were compared with the luminal type A cell line (MCF-7). LncRNA expression was assessed via next-generation sequencing, RNA extraction, lncRNA profiling, and quantitative RT-qPCR...
April 22, 2024: BMC molecular and cell biology
https://read.qxmd.com/read/38649679/ck2%C3%AE-mediated-phosphorylation-of-grp94-facilitates-the-metastatic-cascade-in-triple-negative-breast-cancer
#8
JOURNAL ARTICLE
Hye-Youn Kim, Young-Mi Kim, Suntaek Hong
Distant metastasis is a significant hallmark affecting to the high death rate of patients with triple-negative breast cancer (TNBC). Thus, it is crucial to identify and develop new therapeutic strategies to hinder cancer metastasis. While emerging studies have hinted a pivotal role of glucose-regulated protein 94 (GRP94) in tumorigenesis, the exact biological functions and molecular mechanisms of GRP94 in modulating cancer metastasis remain to be elucidated. Our study demonstrated an increased expression of GRP94 in TNBC correlated with metastatic progression and unfavorable prognosis in patients...
April 22, 2024: Cell Death Discovery
https://read.qxmd.com/read/38649531/comparison-of-clinicopathological-and-prognostic-features-of-breast-cancer-patients-younger-than-40-years-and-older-than-65-years
#9
JOURNAL ARTICLE
Yaşar Culha, Sena Ece Davarci, Beyza Ünlü, Duygu Özaşkin, Hacer Demir, Meltem Baykara
PURPOSE: This study aims to compare the clinicopathological and prognostic features of women aged 40 years and younger and 65 years and older with breast cancer. METHODS: Between January 2011 and December 2021, 136 female cases aged 40 years and younger and 223 female cases aged 65 and over were identified among all cases (1395 cases) registered as breast cancer in the file archives of Afyonkarahisar Health Sciences University Faculty of Medicine, Department of Medical Oncology for the study...
April 22, 2024: Discover. Oncology
https://read.qxmd.com/read/38647072/comprehensive-profiling-of-l1-retrotransposons-in-mouse
#10
JOURNAL ARTICLE
Xuanming Zhang, Ivana Celic, Hannah Mitchell, Sam Stuckert, Lalitha Vedula, Jeffrey S Han
L1 elements are retrotransposons currently active in mammals. Although L1s are typically silenced in most normal tissues, elevated L1 expression is associated with a variety of conditions, including cancer, aging, infertility and neurological disease. These associations have raised interest in the mapping of human endogenous de novo L1 insertions, and a variety of methods have been developed for this purpose. Adapting these methods to mouse genomes would allow us to monitor endogenous in vivo L1 activity in controlled, experimental conditions using mouse disease models...
April 22, 2024: Nucleic Acids Research
https://read.qxmd.com/read/38646654/the-hsp90-inhibitor-hvh-2930-exhibits-potent-efficacy-against-trastuzumab-resistant-her2-positive-breast-cancer
#11
JOURNAL ARTICLE
Minsu Park, Eunsun Jung, Jung Min Park, Soeun Park, Dongmi Ko, Juyeon Seo, Seongjae Kim, Kee Dal Nam, Yong Koo Kang, Lee Farrand, Van-Hai Hoang, Cong-Truong Nguyen, Minh Thanh La, Gibeom Nam, Hyun-Ju Park, Jihyae Ann, Jeewoo Lee, Yoon-Jae Kim, Ji Young Kim, Jae Hong Seo
Rationale: Resistance to targeted therapies like trastuzumab remains a critical challenge for HER2-positive breast cancer patients. Despite the progress of several N-terminal HSP90 inhibitors in clinical trials, none have achieved approval for clinical use, primarily due to issues such as induction of the heat shock response (HSR), off-target effects, and unfavorable toxicity profiles. We sought to examine the effects of HVH-2930, a novel C-terminal HSP90 inhibitor, in overcoming trastuzumab resistance. Methods: The effect of HVH-2930 on trastuzumab-sensitive and -resistant cell lines in vitro was evaluated in terms of cell viability, expression of HSP90 client proteins, and impact on cancer stem cells...
2024: Theranostics
https://read.qxmd.com/read/38645685/impact-of-systemic-therapy-on-fertility-in-women-with-early-stage-breast-cancer
#12
JOURNAL ARTICLE
Kelsey H Natsuhara, A Jo Chien
PURPOSE OF REVIEW: Fertility concerns are common among young women diagnosed with breast cancer, as systemic therapy increases the risk of premature ovarian insufficiency and delays family planning. Here, we review the impact of systemic therapies, including chemotherapy, endocrine therapy, HER-2 directed therapy, PARP inhibitors, and immunotherapy, on ovarian reserve. RECENT FINDINGS: With an improved understanding of disease biology, fewer women are treated with gonadotoxic chemotherapy...
March 2024: Current Breast Cancer Reports
https://read.qxmd.com/read/38642908/delays-in-presentation-diagnosis-and-treatment-in-sudanese-women-with-breast-cancer-a-cross-sectional-study
#13
JOURNAL ARTICLE
Esraa S A Alfadul, Badria Tebaig, Salma S Alrawa, Ammar Tarig Elgadi, Ensaf E M A Margani, Maab E B Adam, Mawaheb Sh Adem Mohamoud, Safa A M Elhassan, Moawia Mohammed Ali Elhassan
BACKGROUND: The poor prognosis of breast cancer in Sudan could be due to delayed treatment and diagnosis at an advanced stage. Our study aimed to assess the extent of delays from onset of symptoms to treatment in Sudanese women with breast cancer, as well as identify factors contributing to these delays. MATERIALS AND METHODS: We conducted a multi-center cross sectional study between March and April 2023. Data were collected from the medical records and interviews with women with breast cancer in the two main oncology centers in Sudan...
April 20, 2024: Oncologist
https://read.qxmd.com/read/38640552/financial-toxicity-family-resilience-and-negative-emotions-among-young-and-middle-aged-breast-cancer-patients-a-multicentre-cross-sectional-study
#14
JOURNAL ARTICLE
Xuelei Chen, Qilin Yan, Youjuan Tang, Jianing Zhu, Wenlu Zhang, Jingping Zhang
PURPOSE: To determine financial toxicity in young and middle-aged women with breast cancer and examine the associations between family resilience and negative emotions. METHODS: A multicentre cross-sectional study was conducted, 538 women with breast cancer were recruited from four hospitals. FT, family resilience, and negative emotions were collected using the Comprehensive Score for FT, the Chinese version of the Family Resilience Assessment in Breast Cancer Patients, Patient Health Questionnaire-9 item, and Generalized Anxiety Disorder-7...
April 16, 2024: Breast: Official Journal of the European Society of Mastology
https://read.qxmd.com/read/38639936/postpartum-breast-cancer-and-survival-in-women-with-germline-brca-pathogenic-variants
#15
JOURNAL ARTICLE
Zhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, Heidi D Nelson, Ellen M Velie, Virginia F Borges, Emma R Woodward, D Gareth R Evans, Pepper J Schedin
IMPORTANCE: In young-onset breast cancer (YOBC), a diagnosis within 5 to 10 years of childbirth is associated with increased mortality. Women with germline BRCA1/2 pathogenic variants (PVs) are more likely to be diagnosed with BC at younger ages, but the impact of childbirth on mortality is unknown. OBJECTIVE: To determine whether time between most recent childbirth and BC diagnosis is associated with mortality among patients with YOBC and germline BRCA1/2 PVs. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study included women with germline BRCA1/2 PVs diagnosed with stage I to III BC at age 45 years or younger between 1950 and 2021 in the United Kingdom, who were followed up until November 2021...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38639279/cldn18-clinical-pathological-and-genetic-signatures-with-drug-screening-in-gastric-adenocarcinoma
#16
JOURNAL ARTICLE
Joon Young Hur, Kyueng-Whan Min, Yung-Kyun Noh, Young-Woong Won, Yoomi Yeo, Dong-Hoon Kim, Byoung Kwan Son, Mi Jung Kwon, Jung Soo Pyo
INTRODUCTION: The CLDN18 gene, encoding claudin 18.1 and claudin 18.2, is a key component of tight junction strands in epithelial cells that form a paracellular barrier that is critical in Stomach Adenocarcinoma (STAD). METHODS: Our study included 1,095 patients with proven STAD, 415 from The Cancer Genome Atlas (TCGA) cohort and 680 from the Gene Expression Omnibus database. We applied various analyses, including gene set enrichment analysis, pathway analysis, and in vitro drug screening to evaluate survival, immune cells, and genes and gene sets associated with cancer progression, based on CLDN18 expression levels...
April 18, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38636184/are-there-disparities-in-breast-reconstruction-after-contralateral-prophylactic-mastectomy
#17
JOURNAL ARTICLE
Courtney M Lattimore, Max O Meneveau, Raj Desai, T Fabian Camacho, Gabriella C Squeo, Shayna L Showalter
INTRODUCTION: Despite national guidelines against contralateral prophylactic mastectomy (CPM) in low- to moderate-risk breast cancer, CPM use continues to rise. Breast reconstruction improves health-related quality of life and satisfaction among women undergoing mastectomy. Given the lack of data regarding factors associated with reconstruction after CPM and the known benefits of reconstruction, we sought to investigate whether disparities exist in receipt of reconstruction after CPM...
April 17, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38635308/effectiveness-and-cost-effectiveness-of-survivorship-care-for-survivors-of-hodgkin-lymphoma-insight-study-protocol-for-a-multicenter-retrospective-cohort-study-with-a-quasi-experimental-design
#18
JOURNAL ARTICLE
Eline M J Lammers, Josée M Zijlstra, Valesca P Retèl, Berthe M P Aleman, Flora E van Leeuwen, Annelies Nijdam
BACKGROUND: Hodgkin lymphoma (HL) occurs at young ages, with the highest incidence between 20 and 40 years. While cure rates have improved to 80%-90% over the past decades, survivors of HL are at substantial risk of late treatment-related complications, such as cardiovascular diseases, breast cancer, severe infections, and hypothyroidism. To reduce morbidity and mortality from late treatment effects, the Dutch Better care after lymphoma, Evaluation of long-term Treatment Effects and screening Recommendations (BETER) consortium developed a survivorship care program for 5-year survivors of HL that includes risk-based screening for and treatment of (risk factors for) late adverse events...
April 18, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38633284/association-between-18-f-fdg-pet-activity-and-her2-status-in-breast-cancer-brain-metastases
#19
JOURNAL ARTICLE
Jonathan R Young, Julie A Ressler, Joanne E Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T Chen
PURPOSE: The objective of this study was to evaluate whether uptake on 18 F-fluorodeoxyglucose (18 F-FDG) PET could help differentiate HER2-positive from HER2-negative breast cancer brain metastases. METHODS: In this retrospective, cross-sectional study of a cohort of 14 histologically proven breast cancer brain metastases, we analyzed both preoperative 18 F-FDG PET/CT and HER2 status of the resected/biopsied brain specimens. The maximum standardized uptake values (SUVmax) of the lesions were normalized to contralateral normal white matter and compared using Mann-Whitney U tests...
May 2024: Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38629003/unusual-metastasis-of-gastric-signet-ring-cell-carcinoma-to-the-breast-a-case-report-of-a-young-moroccan-patient
#20
Mohammed Bendimya, Mouna Kairouani, Mohammed El Magroud, Amal Bennani, Ouissam Al Jarroudi, Sami Aziz Brahmi, Said Afqir
Although gastric cancer is known to be an aggressive tumor that can spread throughout the body, breast metastases are uncommon. This entity is rarely reported in the literature, with an estimated incidence of 0.5 to 1.3%. We report a case of a rare association between a gastric subtype of signet ring cell carcinoma and metastasis to the breast. This uncommon situation is only documented through case reports. Most breast metastases have been detected after diagnosis of primary gastric cancer, during the first year...
March 2024: Curēus
keyword
keyword
9785
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.